| Typicality: | 0.367 |
| Saliency: | 0.274 |
| across several clinical trials | 8 | location |
| cdc → be administered to → approximately 140 human subjects | 8 |
| negative | neutral | positive |
| 0.008 | 0.877 | 0.115 |
| Raw frequency | 8 |
| Normalized frequency | 0.274 |
| Modifier score | 0.500 |
| Perplexity | 88.115 |